Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) reduce proteinuria and slow renal disease progression more effectively than other therapies in patients with chronic kidney disease (CKD). However, differences regarding efficacy and safety between these therapies remain controversial.
Autores:
Dr. Ricardo Silvariño Dr. Pablo Ríos Dra. Graciela Baldovinos Dra. Ma. Alejandra Chichet Dra. Nancy Perg Dra. Laura Solá MSc. Gustavo Saona Dra. Nancy De Souza Dra. Verónica Lamadrid Dra. Liliana Gadola Dr. Ricardo Silvariño Dr. Pablo Ríos Dra. Graciela Baldovinos Dra. Ma. Alejandra Chichet Dra. Nancy Perg Dra. Laura Solá MSc. Gustavo Saona Dra. Nancy De Souza Dra. Verónica Lamadrid Dra. Liliana Gadola
Tipo de publicación:
P. CIENTÍFICAS - Artículos